Zhumadian Central Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT03406819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Zhumadian Central Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

alteplase (Activase) (2 trials)

Drugs in Other Trials (4)

heparin (liquaemin) (2 trials)

nitroprusside (nipride) (2 trials)

sodium chloride (2 trials)

tirofiban (aggrastat) (2 trials)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5